(4-((3-Bromobenzyl)oxy)-3-chlorophenyl)boronic acid

Catalog No. :
ACTIER769
CAS No. :
849062-25-5
Molecular Formula :
C13H11BBrClO3
Molecular Weight :
341.40

IUPAC Name:(4-((3-bromobenzyl)oxy)-3-chlorophenyl)boronic acid

(4-((3-Bromobenzyl)oxy)-3-chlorophenyl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$118.00Login to see priceInquiryInquiry
1g95%$254.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-((3-Bromobenzyl)oxy)-3-chlorophenyl)boronic acid
IUPAC Name(4-((3-bromobenzyl)oxy)-3-chlorophenyl)boronic acid
MDL No.MFCD06411317
Molecular FormulaC13H11BBrClO3
Molecular Weight341.40
SMILESClC1=CC(B(O)O)=CC=C1OCC2=CC=CC(Br)=C2
InChI KeyHKBRUUCYKMOURT-UHFFFAOYSA-N
Synonym4-(3-bromobenzyloxy)-3-chlorophenylboronic acid;Boronic acid, B-[4-[(3-bromophenyl)methoxy]-3-chlorophenyl]-;3-Chloro-4-(3'-bromobenzyloxy)phenylbor&;3-Chloro-4-(3'-bromobenzyloxy)phenylbor&
CAS No.849062-25-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTIER769 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKPTE067 route compound structure diagram
    ACKPTE067182344-13-4 In Stock
  4. Then
  5. ACTIER769 route product structure diagram
    ACTIER769849062-25-5
Inquiry

2. ACTIER769 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKPTE067 route compound structure diagram
    ACKPTE067182344-13-4 In Stock
  4. Then
  5. ACTIER769 route product structure diagram
    ACTIER769849062-25-5
Inquiry

Comments (0)